Skip to main content

Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative.

Chowdary D, Lathrop J, Skelton J, Curtin K, Briggs T, Zhang Y, Yu J, Wang Y, Mazumder A

Publication: J Mol Diagn (2006) • Vol 8 • Page 31-9PMID: 16436632View on PubMed

Purpose

The purpose of this paper was to compare gene expression analysis by microarray of snap-frozen and RNA-later preserved breast and colon tumors.

Conclusion

Comparison of snap-frozen and RNAlater preserved tissues by microarray analysis showed a median Pearson's coefficient of 0.96-0.98, a 1:1 hybridization intensity, generally adjacent hierarchical clustering, and a 95-97% agreement in prediction of recurrence.

Studies (1)

Purpose

The purpose of this study was to compare gene expression analysis by microarray of snap-frozen and RNA-later preserved breast and colon tumors.

Summary of Findings

No significant differences in RNA yield or integrity were found between snap-frozen and RNAlater-preserved breast and colon specimens. The Pearson's correlation coefficient of snap-frozen and RNAlater-preserved specimens was 0.98 for breast tumors and 0.96 for colon tumors. After mutiple testing and correction for false discovery, a comparison of expression of snap-frozen and RNAlater-preserved specimens identified only 2 genes to be differentially expressed between preservation methods in breast tumors and no genes significantly different in colon tumors. Further, the ratio of the hybridization signal from snap-frozen and RNAlater-preserved specimens for each gene was found to be close to 1 and hierarchical clustering could not distinguish between the two preservation methods. When breast tissue was compared with colon tissue, 70% of the genes found to be up-or down regulated between tissue types were identified in both snap-frozen and RNAlater preserved tissues. Finally, the prediction of recurrence was similar between frozen and RNAlater-preserved tissues with 97% agreement for breast tumors and 95% agreement for colon tumors. In conclusion, RNAlater may be used for preservation of tissue specimens for microarray analysis.

  • Biospecimens

    TissueBreast
    TissueColorectal
  • Preservation Types

    RNAlaterFrozen
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    RNASpectrophotometry
    RNAAutomated electrophoresis/Bioanalyzer
    RNADNA microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Breast
    Colon
    Biospecimen PreservationType of fixation/preservation
    RNAlater
    Snap frozen